BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24397346)

  • 1. Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease.
    Shen SJ; Hu ZX; Li QH; Wang SM; Song CJ; Wu DD; He JL; Guan JC; Shan JP
    Nephrology (Carlton); 2014 Mar; 19(3):129-35. PubMed ID: 24397346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney function assessed by eGFR, cystatin C and NGAL (neutrophil gelatinase-associated lipocalin) in relation to age in heart allograft recipients.
    Przybylowski P; Malyszko J; Malyszko J
    Med Sci Monit; 2010 Sep; 16(9):CR440-4. PubMed ID: 20802417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative assessment of neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C as early biomarkers for early detection of renal failure in patients with hypertension.
    Gharishvandi F; Kazerouni F; Ghanei E; Rahimipour A; Nasiri M
    Iran Biomed J; 2015; 19(2):76-81. PubMed ID: 25864811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine, and glomerular filtration rate in patients after heart and lung transplantation.
    Szewczyk M; Wielkoszyński T; Zakliczyński M; Zembala M
    Transplant Proc; 2009 Oct; 41(8):3242-3. PubMed ID: 19857721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients.
    Malyszko J; Malyszko JS; Bachorzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
    Transplant Proc; 2009; 41(1):158-61. PubMed ID: 19249502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of atorvastatin on NGAL and cystatin C in chronic kidney disease: a post hoc analysis of the LORD trial.
    Fassett RG; Robertson IK; Ball MJ; Geraghty DP; Cardinal JW; Coombes JS
    Nephrol Dial Transplant; 2012 Jan; 27(1):182-9. PubMed ID: 21543653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil gelatinase-associated lipocalin and cystatin C could predict renal outcome in patients undergoing kidney allograft transplantation: a prospective study.
    Lebkowska U; Malyszko J; Lebkowska A; Koc-Zorawska E; Lebkowski W; Malyszko JS; Kowalewski R; Gacko M
    Transplant Proc; 2009; 41(1):154-7. PubMed ID: 19249501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease.
    Malyszko J; Bachorzewska-Gajewska H; Malyszko JS; Pawlak K; Dobrzycki S
    Nephrology (Carlton); 2008 Apr; 13(2):153-6. PubMed ID: 18275504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma neutrophil-gelatinase-associated lipocalin and cystatin C could early diagnose contrast-induced acute kidney injury in patients with renal insufficiency undergoing an elective percutaneous coronary intervention.
    Liu XL; Wang ZJ; Yang Q; Yu M; Shen H; Nie B; Han HY; Gao F; Zhou YJ
    Chin Med J (Engl); 2012 Mar; 125(6):1051-6. PubMed ID: 22613530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil gelatinase--associated lipocalin predicts acute kidney injury in patients undergoing liver transplantation.
    Portal AJ; McPhail MJ; Bruce M; Coltart I; Slack A; Sherwood R; Heaton ND; Shawcross D; Wendon JA; Heneghan MA
    Liver Transpl; 2010 Nov; 16(11):1257-66. PubMed ID: 21031541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.
    Bolignano D; Lacquaniti A; Coppolino G; Donato V; Campo S; Fazio MR; Nicocia G; Buemi M
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):337-44. PubMed ID: 19176795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil gelatinase-associated lipocalin, cystatin C and eGFR indicate acute kidney injury and predict prognosis of patients with acute pulmonary embolism.
    Kostrubiec M; Łabyk A; Pedowska-Włoszek J; Dzikowska-Diduch O; Wojciechowski A; Garlińska M; Ciurzyński M; Pruszczyk P
    Heart; 2012 Aug; 98(16):1221-8. PubMed ID: 22705926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and urinary neutrophil gelatinase-associated lipocalin levels in children with chronic renal diseases.
    Nishida M; Kawakatsu H; Okumura Y; Hamaoka K
    Pediatr Int; 2010 Aug; 52(4):563-8. PubMed ID: 20059722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in heart allograft recipients.
    Przybylowski P; Malyszko J; Malyszko JS
    Transplant Proc; 2010 Jun; 42(5):1797-802. PubMed ID: 20620526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease.
    Bolignano D; Lacquaniti A; Coppolino G; Campo S; Arena A; Buemi M
    Kidney Blood Press Res; 2008; 31(4):255-8. PubMed ID: 18600028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease.
    Mitsnefes MM; Kathman TS; Mishra J; Kartal J; Khoury PR; Nickolas TL; Barasch J; Devarajan P
    Pediatr Nephrol; 2007 Jan; 22(1):101-8. PubMed ID: 17072653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values?
    Bachorzewska-Gajewska H; Malyszko J; Sitniewska E; Malyszko JS; Pawlak K; Mysliwiec M; Lawnicki S; Szmitkowski M; Dobrzycki S
    Kidney Blood Press Res; 2007; 30(6):408-15. PubMed ID: 17901710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease.
    Malyszko J; Bachorzewska-Gajewska H; Sitniewska E; Malyszko JS; Poniatowski B; Dobrzycki S
    Ren Fail; 2008; 30(6):625-8. PubMed ID: 18661413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early diagnostic markers for contrast nephropathy in patients undergoing coronary angiography.
    Shaker OG; El-Shehaby A; El-Khatib M
    Angiology; 2010 Nov; 61(8):731-6. PubMed ID: 20529972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in patients with chronic heart failure and coronary artery disease.
    Poniatowski B; Malyszko J; Bachorzewska-Gajewska H; Malyszko JS; Dobrzycki S
    Kidney Blood Press Res; 2009; 32(2):77-80. PubMed ID: 19287180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.